BridgeMD
New treatment option for Maxillary Sinus Augmentation
Official title Radiographical, Histomorphometrical and Biomarker Analysis After Maxillary Sinus Augmentation Utilizing Xenograft Particulate Bone Graft Mixed With Parathyroid Hormone
ClinicalTrials.gov ID: NCT07459075
What this study is testing
- What it's testing
- This study aimed the to investigate the beneficial effect of combining PTH with bovine-derived bone graft bone in maxillary sinus augmentation. There is limited information available about the effect of PTH on maxillary sinus augmentation to achieve a clear understanding of PTH's efficacy in bone regeneration and bone remodelling through radiological, clinical, biomarker, histological and histomorphometric assessment .
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Healthy individuals without any systemic disease/local pathological lesion at the sinus zone that compromise the bone healing potential.
- Fair to good oral hygiene.
- Patient's age ≥ 18 years.
- The RBH was 3 mm or less. Atrophic edentulous posterior maxillary ridge (missing tooth or teeth in the sinus zone), with adequate ridge width (≥ 5...
- Healed planned implant insertion site.
You likely can't join if
- Medically compromised patients with any of the following conditions that could interfere with normal healing potential or osseointegration such as...
- The RBH ˃ 3 mm.
- Thickness of the SM ˃ 5 mm.
- Maxillary sinusitis (acute and chronic) or any other pathologies in the MS.
- Previous MS surgery.
- Heavy smoking ˃ 20 cigarettes daily and/or alcohol abuse.
See the full eligibility criteria
- Healthy individuals without any systemic disease/local pathological lesion at the sinus zone that compromise the bone healing potential.
- Fair to good oral hygiene.
- Patient's age ≥ 18 years.
- The RBH was 3 mm or less. Atrophic edentulous posterior maxillary ridge (missing tooth or teeth in the sinus zone), with adequate ridge width (≥ 5 mm) to accommodate an average DI diameter and to gain primary implant...
- Healed planned implant insertion site.
- Medically compromised patients with any of the following conditions that could interfere with normal healing potential or osseointegration such as uncontrolled diabetes mellitus, currently on chemotherapy...
- The RBH ˃ 3 mm.
- Thickness of the SM ˃ 5 mm.
- Maxillary sinusitis (acute and chronic) or any other pathologies in the MS.
- Previous MS surgery.
- Heavy smoking ˃ 20 cigarettes daily and/or alcohol abuse.
- Parafunctional habits such as severe bruxism and clenching.
The study team makes the final eligibility decision.
Where it's taking place
- Baghdad, Iraq
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Baghdad, Iraq. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.